IST:SURGY Income Statement

Financials in millions TRY. Fiscal year is January - December.

Millions TRY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Selling, General & Administrative	203.32	198.85	126.94	91.98
Other Operating Expenses	-492.15	3.04	1.85	-8.46
Total Operating Expenses	-288.83	201.9	128.78	83.53
Operating Income	288.83	-201.9	-128.78	-83.53
Interest Expense	-30.45	-1.09	-	-
Interest & Investment Income	-18.8	114.12	-	-
Currency Exchange Gain (Loss)	1.36	0.36	-2.3	-0.15
Other Non-Operating Income	-103.52	-204.72	-47.55	-51.63
EBT Excluding Unusual Items	137.41	-293.23	-178.63	-135.31
Gain (Loss) on Sale of Investments	19.49	175.76	12.76	-
Asset Writedown	645.05	909.18	1,478	747.19
Pretax Income	801.95	791.71	1,313	611.88
Income Tax Expense	-796.15	462.95	-	-
Net Income	1,598	328.76	1,313	611.88
Net Income to Common	1,598	328.76	1,313	611.88
Net Income Growth	155.05%	-74.95%	114.51%	-
Basic Shares Outstanding	168	168	168	70
Diluted Shares Outstanding	168	168	168	70
Shares Change (YoY)	-9.14%	-	139.29%	-
EPS (Basic)	9.54	1.96	7.84	8.74
EPS (Diluted)	9.54	1.96	7.84	8.74
EPS Growth	180.71%	-74.95%	-10.36%	-
EBITDA	290.72	-200.23	-128.13	-83.47
D&A For Ebitda	1.89	1.67	0.65	0.05
EBIT	288.83	-201.9	-128.78	-83.53
Effective Tax Rate	-	58.48%	-	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.